Olaf Prante

3.6k total citations
110 papers, 2.5k citations indexed

About

Olaf Prante is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Olaf Prante has authored 110 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Radiology, Nuclear Medicine and Imaging, 45 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Olaf Prante's work include Radiopharmaceutical Chemistry and Applications (28 papers), Peptidase Inhibition and Analysis (27 papers) and Receptor Mechanisms and Signaling (24 papers). Olaf Prante is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (28 papers), Peptidase Inhibition and Analysis (27 papers) and Receptor Mechanisms and Signaling (24 papers). Olaf Prante collaborates with scholars based in Germany, Austria and United States. Olaf Prante's co-authors include Simone Maschauer, Torsten Kuwert, Peter Gmeiner, Harald Hübner, Roland Haubner, Carsten Hocke, Christian Schmidkonz, Jürgen Einsiedel, Michael Uder and Philipp Ritt and has published in prestigious journals such as Angewandte Chemie International Edition, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Olaf Prante

108 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf Prante Germany 29 1.1k 858 694 495 476 110 2.5k
Lixin Lang United States 39 1.7k 1.5× 1.1k 1.3× 1.3k 1.8× 616 1.2× 475 1.0× 125 4.3k
Tobias L. Roß Germany 30 1.3k 1.1× 497 0.6× 583 0.8× 913 1.8× 171 0.4× 109 2.8k
Peter Johnström Sweden 24 1.2k 1.0× 620 0.7× 688 1.0× 1.3k 2.7× 231 0.5× 74 3.4k
Bertrand Kühnast France 31 1.1k 1.0× 1.2k 1.4× 576 0.8× 121 0.2× 363 0.8× 99 3.1k
Joseph C. Walsh United States 23 926 0.8× 755 0.9× 328 0.5× 200 0.4× 269 0.6× 31 3.1k
Simone Maschauer Germany 23 619 0.5× 596 0.7× 527 0.8× 116 0.2× 348 0.7× 70 1.5k
Daniëlle J. Vugts Netherlands 40 2.2k 1.9× 887 1.0× 1.2k 1.8× 595 1.2× 115 0.2× 138 4.1k
Samuel Samnick Germany 34 1.4k 1.2× 597 0.7× 974 1.4× 565 1.1× 347 0.7× 131 3.5k
Stefan Wagner Germany 27 517 0.5× 740 0.9× 619 0.9× 310 0.6× 89 0.2× 89 2.1k
Safiye Osman United Kingdom 24 1.3k 1.1× 541 0.6× 356 0.5× 292 0.6× 479 1.0× 38 2.3k

Countries citing papers authored by Olaf Prante

Since Specialization
Citations

This map shows the geographic impact of Olaf Prante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Prante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Prante more than expected).

Fields of papers citing papers by Olaf Prante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Prante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Prante. The network helps show where Olaf Prante may publish in the future.

Co-authorship network of co-authors of Olaf Prante

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Prante. A scholar is included among the top collaborators of Olaf Prante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Prante. Olaf Prante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhu, Sha, et al.. (2023). Bioconjugation of a Fibroblast Activation Protein Targeted Interleukin-4. ACS Biomaterials Science & Engineering. 9(10). 5580–5588. 1 indexed citations
4.
Schindler, Lisa, et al.. (2022). Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors. Scientific Reports. 12(1). 15028–15028. 3 indexed citations
5.
Popp, Vanessa, Simone Maschauer, Olaf Prante, et al.. (2022). Non-Invasive Characterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT. Cancers. 14(10). 2482–2482. 1 indexed citations
6.
Maschauer, Simone, Hiroyuki Kobayashi, Peter Gmeiner, et al.. (2021). Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer. Communications Biology. 4(1). 1062–1062. 10 indexed citations
7.
Shinde, Sandip S., Simone Maschauer, & Olaf Prante. (2021). Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects. Pharmaceuticals. 14(11). 1175–1175. 16 indexed citations
8.
Shinde, Sandip S., et al.. (2021). 18F-Fluorination Using Tri-Tert-Butanol Ammonium Iodide as Phase-Transfer Catalyst: An Alternative Minimalist Approach. Pharmaceuticals. 14(9). 833–833. 6 indexed citations
9.
Maschauer, Simone, Olaf Prante, Peter Gmeiner, et al.. (2020). Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine‐Derived Phenylazocarboxamides as Novel μ‐Opioid Receptor Ligands. ChemMedChem. 15(13). 1175–1186. 5 indexed citations
10.
Maschauer, Simone, et al.. (2020). Pharmacological Characterization of Low-to-Moderate Affinity Opioid Receptor Agonists and Brain Imaging with 18F-Labeled Derivatives in Rats. Journal of Medicinal Chemistry. 63(17). 9484–9499. 5 indexed citations
11.
Kuwert, Torsten, et al.. (2020). Development of 18F-Fluoroglycosylated PSMA-Ligands with Improved Renal Clearance Behavior. Molecular Pharmaceutics. 17(3). 933–943. 24 indexed citations
12.
Schmidkonz, Christian, Manuela Krumbholz, Armin Atzinger, et al.. (2019). Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA. European Journal of Nuclear Medicine and Molecular Imaging. 47(6). 1564–1575. 14 indexed citations
13.
Maschauer, Simone, et al.. (2017). [18F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ-Opioid Receptor. ACS Omega. 2(12). 8649–8659. 14 indexed citations
14.
Stößel, Anne, Nirupam Purkayastha, Harald Hübner, et al.. (2017). Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior. Bioorganic & Medicinal Chemistry. 25(13). 3491–3499. 8 indexed citations
15.
Maschauer, Simone, et al.. (2016). In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor. Molecules. 21(9). 1144–1144. 14 indexed citations
16.
Maschauer, Simone, Philipp Tripal, Roland Haubner, et al.. (2014). In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study. Pharmaceuticals. 7(4). 464–481. 17 indexed citations
17.
Vogt, Michael, et al.. (2012). High frequency ultrasonic imaging based on a combination of synthetic aperture focusing and limited angle compounding: Small animals imaging results. 38–41. 1 indexed citations
18.
Maschauer, Simone, Catherine A. Foss, Sridhar Nimmagadda, et al.. (2011). Effects of Recombinant Human Thyroid-Stimulating Hormone Superagonists on Thyroidal Uptake of 18 F-Fluorodeoxyglucose and Radioiodide. Thyroid. 21(7). 783–792. 12 indexed citations
19.
Hocke, Carsten, Olaf Prante, Ismail Salama, et al.. (2008). 18F‐Labeled FAUC 346 and BP 897 Derivatives as Subtype‐Selective Potential PET Radioligands for the Dopamine D3 Receptor. ChemMedChem. 3(5). 788–793. 20 indexed citations
20.
Hocke, Carsten, Olaf Prante, Stefan Löber, et al.. (2005). Synthesis and evaluation of 18F-labeled dopamine D3 receptor ligands as potential PET imaging agents. Bioorganic & Medicinal Chemistry Letters. 15(21). 4819–4823. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lixin Lang Breakdown of academic impact, for papers by Tobias L. Roß Breakdown of academic impact, for papers by Peter Johnström Breakdown of academic impact, for papers by Bertrand Kühnast Breakdown of academic impact, for papers by Joseph C. Walsh Breakdown of academic impact, for papers by Simone Maschauer Breakdown of academic impact, for papers by Daniëlle J. Vugts Breakdown of academic impact, for papers by Samuel Samnick Breakdown of academic impact, for papers by Stefan Wagner Breakdown of academic impact, for papers by Safiye Osman
Rankless by CCL
2026